# Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring

> **NCT00836212** · PHASE4 · UNKNOWN · sponsor: **University Hospital, Geneva** · enrollment: 12 (estimated)

## Conditions studied

- Human Immunodeficiency Virus
- HIV Infections

## Interventions

- **DRUG:** Reducing dose of Lopinavir
- **DRUG:** Reducing dose of efavirenz

## Key facts

- **NCT ID:** NCT00836212
- **Lead sponsor:** University Hospital, Geneva
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-03
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2009-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00836212

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00836212, "Adjusting Antiretroviral Therapy Dosage Using Therapeutic Drug Monitoring". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00836212. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*